Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
4.15
↑ 354% above average
Average (5y)
-1.63
Historical baseline
Range
High:4.15
Low:-16.30
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 4.15 | +24.2% |
| 2023 | 3.34 | +208.6% |
| 2022 | 1.08 | -69.1% |
| 2021 | 3.50 | +162.9% |
| 2020 | -5.56 | +65.9% |
| 2019 | -16.30 | - |